U.S. market Closed. Opens in 11 hours 18 minutes

VCNX | Vaccinex, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue570.00K100.00K900.00K50.00K523.00K724.00K90.00K316.00K
Cost of Revenue119.00K207.00K169.00K2.00K199.00K1.03M160.00K115.00K
Gross Profit451.00K-107.00K731.00K48.00K324.00K-309.00K-70.00K201.00K
Operating Expenses23.34M20.01M23.39M28.38M32.34M26.97M21.03M20.46M
Selling, General & Admin6.88M6.20M6.23M7.41M6.67M4.62M4.48M4.43M
Research & Development16.45M13.98M17.16M21.55M25.67M22.35M16.55M16.03M
Other Operating Expenses912.00K-175.00K43.00K-575.00K152.00K165.00KN/AN/A
Operating Income-22.89M-19.91M-22.49M-28.33M-32.02M-27.28M-21.10M-20.26M
Other Expenses / Income2.63M91.00K110.00K-520.00K152.00K-1.84M2.35M6.32M
Before Tax Income-20.25M-19.82M-22.38M-28.85M-31.86M-29.52M-18.76M-13.94M
Income Tax Expenses-48.90K-93.00K852.00K458.00K152.00K-1.84MN/AN/A
Net Income-20.25M-19.72M-23.23M-29.31M-32.02M-29.52M-18.72M-13.94M
Interest Expenses1.00K2.00K809.00K489.00KN/A392.00K1.36M2.99M
Basic Shares Outstanding463.65K202.08K136.63K89.46K61.34K348.24K7.94M7.94M
Diluted Shares Outstanding463.65K202.08K137.38K89.46K61.34K348.24K7.94M7.94M
EBITDA-22.77M-19.61M-22.28M-28.05M-31.61M-26.89M-17.16M-10.78M
EBITDA Margin-3,994.04%-19,606.00%-2,475.33%-56,110.00%-6,044.74%-3,714.50%-19,064.44%-3,409.81%
EBIT-20.30M-19.81M-21.57M-28.36M-31.86M-30.97M-17.36M-10.95M
EBIT Margin-3,561.21%-19,813.00%-2,396.78%-56,724.00%-6,092.35%-4,277.76%-19,293.33%-3,466.14%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙